Company Long-Term Liabilities: Haleon PLC (HLN)

Graphic logo of Haleon Corp (HLN)

Haleon plc (HLN) management is focusing on margin growth and liability reduction following the business spin-off. The trend of the corporation's long-term loans and borrowings confirms this trajectory, with the latest value recorded as 8.39. The company's resilience is based on its global reach in crisis-resistant over-the-counter products, while high brand equity is ensured by years of consumer trust in the safety of pharmacy products.

HLN haleon.com: Company Long-Term Liabilities in the range 04/28/2023 - 10/31/2026
Manufactured product of Haleon PLC

Professional capital evaluates the profile of Haleon plc (HLN) through the lens of leverage stability. By analyzing the firm's long-term borrowings, the investor tracks the dynamics of liabilities with maturities exceeding one year to understand the debt load. A stable debt level allows Haleon plc (HLN) to invest in a highly qualified staff of researchers and marketers. Such financial discipline confirms the asset's reliability and guarantees social benefits for employees.

Who Haleon plc competes with

Company Long-Term Loans and Borrowings KVUE|VRNA - Company Long-Term Debt|Jyong Biotech Limited (MENS) - Company Long-Term Liabilities|LGND: Company Long-Term Debts|Amneal Corp (AMRX) - Company Long-Term Debts|Company Long-Term Liabilities PRGO|ALVO: Company Long-Term Loans and Borrowings|Company Long-Term Debt Liquidia (LQDA)|GLPG - Long-Term Debt|ANI Pharma - Company Long-Term Liabilities|Amount of Long-Term Liabilities MNKD (Afrezza)|Amphastar Pharmaceuticals - Company Long-Term Debts|Company Long-Term Loans and Borrowings PCRX (pacira.com)|SPRY: Company Long-Term Debts|Long-Term Debt Theravance Biopharma Inc (TBPH)|Company Long-Term Debt Aquestive Pharma|SCPH: Company Long-Term Loans and Borrowings|Company Long-Term Debts TECX|TNXP (tonixpharma.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts SXTC (China SXT Pharmaceuticals, Inc.)|Company Long-Term Debts Eupraxia Pharmaceuticals, Inc. EPRX|BHST - Company Long-Term Debt|EXOZ: Company Long-Term Debt|ORMP: Company Long-Term Debts|Long-Term Debt Entera Bio (ENTX)|Company Long-Term Debt MindWalk Holdings Inc.|Long-Term Debt ABVC BioPharma Inc. ABVC|Company Long-Term Debt Cumberland Pharma (CPIX)|Quantum BioPharma Corp - Company Long-Term Indebtedness|FibroGen, Inc. - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings TELO|RANI - Company Long-Term Debt|Long-Term Liabilities SNYR|rallybio.com (RLYB) - Company Long-Term Debt|LEXX (Lexaria Bioscience Corp.) - Company Long-Term Debt|PULM (Pulmatrix, Inc.) - Company Long-Term Debts|Company Long-Term Liabilities Pheton (PTHL)|Company Long-Term Debts APM|LYRA (Lyra Therapeutics Inc.) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Impact BioMedical Inc IBO|TNF Pharmaceuticals Inc. - Company Long-Term Debt|YCBD - Company Long-Term Debt|PRFX (painreform.com) - Company Long-Term Indebtedness|altamiratherapeutics.com (CYTO) - Company Long-Term Debt|Long-Term Liabilities LIPO (Lipella Pharmaceuticals Inc)|OPTN (Optinose) - Company Long-Term Debts|PIRS: Company Long-Term Loans and Borrowings|Company Long-Term Debts PROC|Company Long-Term Debts petrospharma.com (PTPI)|Company Long-Term Debt Qilian International Holding QLI|Company Long-Term Loans and Borrowings SLRN|TFFP - Company Long-Term Debt